Demand for small batches of pharmaceuticals and medical devices has exploded in recent years, owing to a number of factors, including the rise of personalized medicines and orphan drugs and the industry need to produce small batches economically. This has led to larger pharmaceutical manufacturers and CMOs (Contract Manufacturing Organisations) struggling to accommodate occasional low volumes on their high-speed production lines.
Sepha has introduced the new service in response to this challenge amid increasing calls for support from its larger pharmaceutical customers.